Clinical trial
CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention…
NCT00246207 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00246207 |
|---|---|
| Title | CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults |
| Official title | An Open-label Study Evaluating the Safety and Effectiveness of OROS Methylphenidate Hydrochloride (CONCERTA) in Adults With Attention Deficit Hyperactivity Disorder |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug |
| Interventions | CONCERTA (OROS methylphenidate hydrochloride) |
| Enrollment | 32 |
| Start date | Mar 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 31, 2005 |
| Last update posted | Feb 10, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: